Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin XR add-on for clozapine-associated weight gain prevention in schizophrenia
ACTRN12617001547336Phase 4Recruiting
- Sponsor
- The University of Queensland
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in schizophrenia and schizoaffective disorder comparing Metformin XR adjunct arm with Placebo adjunct arm (2 arms). Primary endpoint: Body weight. Started Mar 2018; status: recruiting.
02
Drugs
metformin
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on ACTRN12617001547336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001547336.